Practical reading from Professor Paul Lee and the Lincolnshire Hip Clinic team — across hip replacement, Arthrosamid, ChondroFiller, PRP and the wider world of hip and groin pain.
ChondroFiller is an injectable collagen scaffold that gels in the hip joint and is remodelled by the patient's own cells into fibrocartilage-like repair tissue over three to six months. It is intended for mild-to-moderate osteoarthritis where joint space remains visible but conservative treatment has plateaued and total hip replacement is not yet necessary.
Focal hip cartilage defects are now treatable by two structurally distinct routes: ChondroFiller injection, an outpatient ultrasound-guided collagen scaffold, or hip OATS, a surgical bone-cartilage graft. No trial has directly compared them, and suitability depends on patient fitness, recovery capacity, and defect location as much as size.
A collagen scaffold injected into the hip gels in 3–5 minutes and prompts the body's own repair cells to regenerate focal cartilage damage. Candidacy requires ICRS Grade III–IV damage (2–6 cm²), preserved joint space, and prior failed conservative management.
ChondroFiller hip injection candidacy requires a focal ICRS grade III–IV lesion of 2–6 cm² surface area within a hip joint that retains sufficient structure on weight-bearing X-ray.
ChondroFiller targets focal hip cartilage defects — isolated damage, not diffuse wear — using an injectable collagen scaffold that recruits the patient's progenitor cells to repair the lesion. Seventy to eighty-five per cent of appropriately selected patients achieve meaningful symptom relief within three to five years.
Hip osteoarthritis pain sits deep in the groin and front of the thigh rather than the outer hip, progressing slowly enough that most patients manage without surgery for 10–20 years.
ChondroFiller is a collagen gel that recruits the body's progenitor cells to repair hip cartilage defects and then resorbs entirely. In a 26-patient cohort treated arthroscopically, 81% achieved good or excellent outcomes with sustained improvement over five years.
Hip cartilage repair or replacement is determined by three interacting clinical variables—defect size, osteoarthritis stage, and age—not any single factor; bone-on-bone contact (joint space under 2 mm) typically marks when replacement is appropriate.
Hip fractures deteriorate rapidly without treatment; surgical repair within 36 hours of admission substantially reduces complications and improves survival, particularly in older patients.
Lincolnshire Hip Clinic
Led by Professor Paul Lee
Start with a free, non-medical discovery call with our team. We will tell you, honestly, which of our pathways — surgical or non-surgical — fits your situation. No GP referral, no pressure to proceed.
What we offer
